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Introduction
Anaemia is a common problem, particularly among older people (aged 65 and over) (Beghe et al, 2004; Guralnik et al, 2004; Craig et al, 2007) . Although the underlying cause is not identified in up to one in three cases (Penninx et al, 2006; Tettamanti et al, 2010) , many diseases and conditions are associated with anaemia, including cancer, chronic kidney disease, chronic inflammation, congestive heart failure, iron deficiency and other nutritional deficiencies, bone marrow failure and malnutrition (Penninx et al, 2006) . Anaemia is also associated with depression (Onder et al, 2005) . The cause of anaemia may affect haemoglobin concentration, with most studies finding that haemoglobin concentrations are lowest in those with iron deficiency anaemia, closest to normal in anaemia of inflammation, with unexplained anaemia in between (Merchang et al, 2012) .
Regardless of cause, individuals with anaemia have increased mortality (Chaves et al, 2004; Zakai et al, 2005; Culleton et al, 2006; Bross et al, 2010) and morbidity, including hospitalization (Penninx et al, 2006; Culleton et al, 2006) , physical disability (Maraldi et al, 2006) , poor physical function and falls (Penninx et al, 2005) , and fracture incidence (Chen et al, 2010) , and more rapid decline in cognitive function (Shah et al, 2011) .
Anaemia affects disease-related mortality, morbidity and quality of life (Spivak et al, 2005; Zakai et al 2005) , independently of prevalent diseases at baseline (Penninx et al, 2005; Penninx et al, 2006; Shah et al, 2011) , though some associations are due primarily to comorbidity (Maraldi et al, 2006 (Isaks et al, 1999; Patel et al, 2009 ). These criteria were developed in 1968, based on statistical distributions equivalent to two standard deviations below the mean in a reference sample aged <65 years. Thresholds defining anaemia in older populations have been the subject of considerable scientific debate. Some studies used lower, non-sex specific, thresholds for anaemia among the elderly, including <11g/dl (Culleton et al 2006) and <11.5g/dl (Joosten et al 1992) . Riva et al (2009) used <10.0 g/dl to differentiate "Severe anaemia", from "Mild anaemia" (>=10 but under the WHO limits). Others have used higher, sex specific thresholds: 0.2g/dl above WHO limits (Beutler and Waalen 2006) ; and 0.1-2.0g/dl above WHO limits, i.e. "low-normal haemoglobin" (Penninx et al, 2006; Chaves et al, 2002) .
Additionally, three studies in older adults have shown elevated mortality amongst those in the highest and in the lowest quintiles of haemoglobin levels, (Zakai et al, 2005; Culleton et al, 2006) , even after extensive adjustment for other factors (Dharmarajan et al, 2005) . This paper investigates which haemoglobin levels are associated with all-cause mortality in adults in the general population and examined the effects of different haemoglobin levels on mortality, to contribute to the debate on the thresholds for harmful haemoglobin levels in older people.
Materials and Methods

Participants
The Health Survey for England (HSE) is an annual, cross-sectional survey of a nationally representative sample of adults and children living in private households in England (Mindell et al, 2012) . Each year, core modules of questions and measurements are supplemented by population boosts and/or or additional topics. In 1998 and 2006, modules were included on cardiovascular disease and physical activity; in 2005, the HSE focused on the health, risk factors, and determinants of health of people aged 65+ (Erens et al, 2000; Craig et al, 2007; Craig et al, 2008) .
Data collection
The sampling design and method have been described in detail elsewhere (Erens et al, 2000; Craig et al, 2007; Craig et al, 2008) . A random sample was selected each year using a two-stage, stratified process. After sending a letter, an interviewer visited the address to recruit the participants and conduct the interviews, using computer-assisted personal interviewing (CAPI).
Household-level socio-demographic data included equivalised household income (income adjusted for the number of adults and children in the household). Individuallevel socio-demographic data (occupational social class and years of education) were supplemented by questions about general self-reported health, smoking, (other health behaviours had been measured in non-comparable ways in different survey years), and doctor-diagnosed cardiovascular conditions (CVD, namely stroke, myocardial infarction, angina, dysrhythmia, heart murmur or other heart condition, not asked of half the sample aged 65+ in 2006).
Participants were also asked whether they had "any longstanding illness, disability or infirmity". Those who replied 'yes' were asked whether this had limited their daily activities or the work that they could do in any way. The interviewer also measured height and weight. After the interviewer visit, non-fasting blood samples were obtained from consenting adults during a nurse visit. For participants who gave consent for their data to be linked to NHS records, their identifying information was sent to the NHS, to be flagged as an HSE participant. The mortality data for all flagged respondents was extracted in January 2011, stating for each person whether or not they had died, and if so, when.
Blood samples were posted to the Department of Clinical Biochemistry at the Royal Victoria Infirmary, Newcastle for analysis. Haemoglobin was measured on Abbott Diagnostics Cell-Dyn 4000 analysers. Further details of laboratory measurements and of quality control are available elsewhere (Erens et al, 2000; Craig et al, 2007; Craig et al, 2008) .
Ethical approval
Ethical approval for the three surveys was obtained from the London Multi-centre Research Ethics Committee (MREC) prior to the surveys. All participants gave oral consent to be interviewed and have measurements made, and written consent to have blood samples taken and mortality data linked to the survey data.
Statistical analysis
Analyses in this paper include participants aged 65+ from HSE 1998 HSE , 2005 HSE and 2006 who had given consent for their data to be linked to mortality data, and had provided a valid haemoglobin sample (Table 1 ). Haemoglobin levels vary by race/ethnicity and the impact on mortality of a given level may also vary (Denny et al 2006; Patel et al 2007; Dong et al 2008; Patel et al 2009) . As numbers from non-white groups were too small for separate analysis (1.5% were non-white), this paper is restricted to data from people of a white ethnic background. Overall, 51% of those interviewed who were included in the analysis.
Haemoglobin results were grouped in two ways: by sex-specific quintile, and by bands defined by 1g/dl relative to the WHO criteria for each sex (haemoglobin <13g/dl [<8.1mmol/l] in men and <12g/dl [<7.5mmol/l] in women). People taking iron or other hematinics were also excluded from these analyses. With the data available, it was not possible to distinguish the cause of anaemia, therefore only haemoglobin results were used for the categorization.
Non-response weighting was introduced to HSE in 2003, as with other UK government surveys, because of falling response rates. Variables enabling adjustment for complex survey design were also introduced at that time. Except when describing participants' characteristics (Table 2) , the data were weighted for non-response to the blood sample, so that although some groups tended to be over or under-represented in a, the survey and b, the blood sample, this was corrected in the analysis (using weights provided for
Results
Response rates by survey year and sex are provided in Table 1 . Among the sample available for survival analysis, 2446 men and 2863 women aged 65+ provided usable blood samples. Participant characteristics (unweighted and without adjustment for complex survey design) are presented in Table 2 . The prevalence of anaemia (weighted for non-response) was 14% for men and 11% for women, including 5% of men and 3% of women with haemoglobin more than 1g/dl below WHO thresholds. Anaemia prevalence increased with age, from 6% of men aged 65-69, to 31% of those aged 85+, and from 5% to 22% of women. High haemoglobin levels (haemoglobin ≥ 3g/dl above the WHO anaemia threshold) decreased with age, from 13% to 6% among men, and 9% to 4% among women. The modal haemoglobin band was 1-2g/dl above the WHO threshold for both sexes (mean 14.4g/dl in men, 13.4g/dl in women). When adjusted only for age, the highest hazard ratio among men was for the lowest haemoglobin group, <12 g/dl (HR 2.19, 95%CI 1.66-2.90). Mild anaemia (haemoglobin 12.0-12.9 g/dl) was also a significant risk (1.64, 1.31-2.06), as was high haemoglobin (≥ 16g/dl, HR 1.35, 1.04-1.74). For women, only those with more severe anaemia (<11g/dl) had a significant risk (age-adjusted HR. 1.61, 1.08-2.41). Unlike men, neither women with mild anaemia (11.0-11.9 g/dl) nor with high haemoglobin (≥ 15g/dl) had significantly raised hazard ratios (p=0.06 in both cases), but the sample sizes and number of deaths among these groups were smaller for women than men.
When additional variables were added to the model, lower education, current or previous smoking, having a limiting longstanding illness, and being underweight were also associated with mortality (being overweight was associated with survival among women only). After adjustment for these factors, the significance and magnitude of the risk posed by high or low haemoglobin fell slightly for both men and women, but remained significant for men. For men, the highest hazard ratio remained for those with more severe anaemia, <11g/dl (HR 1.87, CI 1.39-2.53). Mild anaemia (haemoglobin 11.0-11.9g/dl) was also a significant risk (1.56, 1.24-1.96), as was high haemoglobin (≥ 16g/dl (1.32 1.02-1.70, Figure 1C ). For women, after adjustment for multiple factors, no haemoglobin band showed significant difference from the reference group, although a non-significant U-shaped association was seen ( Figure 1D ).
Kaplan-Meier curves showed that survival was worst for men with more severe anaemia but was also worse for those with mild anaemia or high haemoglobin, compared with those whose baseline haemoglobin was 0-3g/dl above the WHO thresholds (Figure 2A ).
For women, no significant differences were seen ( Figure 2B ).
Discussion
Anaemia is of concern because of the morbidity and mortality associated both with the abnormally low haemoglobin level and with the underlying cause(s) of the anaemia, a condition which is common and increases with age (Beghe et al 2004; Guralnik et al 2004; Craig et al 2007) . As the population ages and the prevalence of anaemia increases, an understanding of these associations is essential. We have shown that for men, both mild and more severe anaemia were significantly associated with reduced survival, compared with normal haemoglobin, defined using WHO thresholds. The group with the highest levels of haemoglobin (≥ 16g/dl) also had a significantly raised adjusted hazard ratio. It is unclear whether any U shaped or reverse J shaped effect on mortality operates through the same causal pathways at both high and low values. Although anaemia was significantly associated with mortality only in men among these HSE participants, a similar relationship was seen in women but the 95% confidence intervals were wide.
Greater detail about the relationship between haemoglobin level and mortality hazard can be seen using haemoglobin bands than quintiles. This is probably because the lowest and highest quintiles each included people with normal haemoglobin levels, which we have shown was not associated with mortality in our study.
Although the presence of 'low normal' haemoglobin levels has previously been associated with increased morbidity and mortality (Zakai et al 2005; Penninx et al 2006) , there was no association between survival and 'low normal' haemoglobin in HSE participants. Our study provides reassurance that the current WHO thresholds are neither too low, unlike some studies' conclusions (Zakai et al 2005; The main strengths of the study are that it includes a large nationally-representative sample, rather than being a local population or one collected through use of healthcare services. The study includes the use of standardised methods for ascertaining haemoglobin status and relevant confounding factors. It is only the second study to examine a nationally-representative sample of free-living older people.
One limitation of this paper is that people living in institutions were excluded. This group has lower haemoglobin levels and a higher prevalence of anaemia (Bajekal 2002) than the general population but their prevalence of 'low normal' haemoglobin has not been investigated. In HSE 2000, blood samples were obtained from 627 residents of care homes. Overall, 38% of men and 30% of women had anaemia (using WHO criteria), while 24% and 25% respectively had 'low normal' haemoglobin. The prevalence of 'low normal' haemoglobin is not markedly different, although anaemia was far more common in residents of care homes. However, the care home residents in HSE 2000 were much older: 44% of men and 60% of women aged 65+ living in care homes who provided blood samples in HSE 200 were aged 85+, compared with 7% and 8% of men and women aged 65+ in HSE 2005. Also, no information was available on other related nutritional deficiency states, dietary intakes or on dosage of iron in multivitamin supplements.
Longstanding illness was chosen as an explanatory variable for survival rather than selfreported health to avoid reverse causality of poor subjective health due to anaemia.
When factors associated with reduced survival were added into the model, education, smoking, BMI, and longstanding illness were each associated with survival; their inclusion reduced the effect of more severe anaemia in men by 20%, from HR 2.19 to 1.87 (20% is the difference between log 2.19 and log 1.87). The addition of these factors reduced the effect of 'mild' anaemia by 11% and the effect of high haemoglobin by 2%.
No serum creatinine data were available, so we were unable to adjust for chronic kidney disease, which would affect both mortality and haemoglobin levels.
Although only half the participants aged 65 and over in HSE 2005 gave a blood sample, results were weighted to adjust for known characteristics that differed between participants in the interview who did and did not give a blood sample, in addition to the basic non-response weighting. There was no attempt to weight for non-consent to data linkage. However, among those giving a blood sample, the consent rate was very high (92%), so this is unlikely to a major source of response bias.
Numbers were too small to investigate whether using the lower Joostens criteria to define anaemia in older people identified a group at higher risk, however given the sex differences found in our analysis, this supports the use of sex-specific thresholds.
Another limitation was that there were too few participants from non-white ethnic groups to examine ethnic differences in this relationship. The prevalence of anaemia, defined by WHO criteria, is higher in African Americans than Caucasians (Denny et al 2006 , Dong et al 2008 . In some studies, the age-adjusted mortality risk ratio did not differ by sex or race, using the WHO criteria, (Denny et al 2006 , Dong et al 2008 but others found that WHO-defined anaemia was associated with mortality only in white not black adults aged 71-82y; mortality rates in black men were higher only in those whose haemoglobin was below 2g/dl below the WHO threshold (i.e. <11.0g/dl) (Patel et al 2007) . Significantly raised mortality hazard ratio was found in whites but not blacks with 'low normal' haemoglobin (Dong et al 2008) . The NHANES III data found that mortality was raised below race-specific thresholds of 0.2g/dl above the WHO thresholds in Mexican Americans, and 0.7g/dl below the threshold in non-Hispanic blacks (Patel et al 2009) .
Unlike previous reports, our study does not support screening to identify older individuals with 'low normal' haemoglobin. We have confirmed the adverse effect of anaemia and also of high haemoglobin in men on survival, independently of other major risk factors, but did not find any such effect in women. Further studies or longer follow-up of the HSE participants will be required to assess whether this is a problem of low numbers and therefore limited power to confirm the association, or whether there are other explanations, such as differential association between mortality and only some types of anaemia (Semba et al 2007) . Non-manual  47  50  53  50  51  60  60  57  Manual  52  49  46  50  42  36  36  38  Missing  1  0  0  1  6  3  4  5  Equivalised household income  Highest quintile   c   6  9  8  8  4  5  6  5  2nd highest quintile  12  11  10  11  8  8  7  8  3rd quintile  22  19  23  21  18  18  20  19  2nd lowest quintile  27  24  29  27  36  22  37  31  Lowest quintile  19  21  13  18  17  28  12  20  missing  14  15  16  15  17  20  18 
